Engineers Gate Manager LP
Position in RXRX — Recursion Pharmaceuticals, Inc.
CIK 1620220
NEW YORK, NY
Position in RXRX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$656,485
+$603,616 QoQ
Shares Held
213,839
+1873.8% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $199,313,913 across 163 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in RXRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $656,485 | 213,839 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $52,869 | 10,834 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $478,205 | 94,507 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $312,244 | 46,190 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,155,853 | 175,395 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $583,432 | 77,791 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $579,865 | 58,161 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $112,118 | 11,371 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $587,979 | 82,120 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||